| Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip System (NCT04941729) | Smith & Nephew Medical (Shanghai) Ltd | 2022-06-24 |
| A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 (NCT05047341) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-07 |
| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders (NCT05000216) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-08-13 |
| Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA) (NCT04888585) | AbbVie | 2021-06-23 |
| A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis (NCT04541810) | AbbVie | 2021-01-26 |
| A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis (NCT04497597) | AbbVie | 2020-10-16 |
| A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis (NCT04574492) | AbbVie | 2020-10-07 |
| Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets (NCT04340115) | AbbVie | 2020-04-24 |
| An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis (NCT04267536) | AbbVie | 2020-02-06 |
| Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individual Suffering From Rheumatoid Arthritis (NCT07646470) | Osteoflow Health Clinic | 2020-01-30 |
| Poly-L/D-lactide Implant (RegJoint) Versus Tendon Interposition for Trapeziometacarpal Inflammatory Arthritis: a 15-year Follow-up (NCT06804356) | Helsinki University Central Hospital | 2019-10-09 |
| Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis (NCT03971253) | Astellas Pharma Inc | 2019-09-02 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis (NCT03631225) | Sequenom, Inc. | 2019-06-25 |
| A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database (NCT05421442) | Bristol-Myers Squibb | 2019-06-13 |
| A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib (NCT03823378) | AbbVie | 2019-05-13 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) (NCT03823391) | AbbVie | 2019-03-27 |
| A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) (NCT03737708) | Astellas Pharma Korea, Inc. | 2019-02-13 |
| Inflammatory Arthritis and Tango (NCT03840785) | University Hospital, Clermont-Ferrand | 2019-01-08 |
| A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis (NCT03682705) | AbbVie | 2018-10-08 |
| A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) (NCT03660059) | Astellas Pharma China, Inc. | 2018-09-27 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis (NCT03410056) | Amgen | 2018-05-22 |
| Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases (NCT03339089) | AbbVie | 2018-05-18 |
| Effectiveness of Yoga and Combined Exercise in Rheumatoid Arthritis (NCT07072754) | Izmir Katip Celebi University | 2018-02-01 |
| A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) (NCT02955212) | AbbVie | 2018-01-03 |
| A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX (NCT04312815) | SinoMab BioScience Ltd | 2017-12-28 |
| Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service (NCT03223012) | AbbVie | 2017-11-15 |
| A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate (NCT03257852) | Astellas Pharma Inc | 2017-09-29 |
| Niclosamide With Etanercept in Rheumatoid Arthritis (NCT03160001) | Faiq Gorial | 2017-08-15 |
| Use of Acthar in Rheumatoid Arthritis (RA) Related Flares (NCT02541955) | Veena Ranganath, MD, MS | 2017-07-20 |
| A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs (NCT03086343) | AbbVie | 2017-05-09 |
| Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics (NCT02855320) | Assistance Publique - Hôpitaux de Paris | 2017-01-27 |
| UCB Cimzia Pregnancy Follow-up Study (NCT02775656) | UCB BIOSCIENCES, Inc. | 2016-11-01 |
| Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously (NCT02805010) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2016-10-01 |
| A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate (NCT02722694) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2016-08-01 |
| Effect of Siwan Sand Therapy on Pulmonary Functions of Rheumatoid Arthritis Patients (NCT07287696) | Ahram Canadian University | 2016-06-01 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate (NCT02698657) | Astellas Pharma Global Development, Inc. | 2016-02-23 |
| Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept (NCT02353780) | Dr. Larry W. Moreland | 2015-03-01 |
| A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 (NCT02105129) | Hutchison Medipharma Limited | 2014-05-01 |
| Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients (NCT01915537) | Zhang, Xiao, M.D. | 2013-08-01 |
| Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents (NCT01691014) | Pfizer | 2013-04-01 |
| Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. (NCT01835613) | Osservatorio Epidemiologico GISEA | 2013-01-01 |
| Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient (NCT01871961) | medac GmbH | 2012-10-01 |
| Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) (NCT01569152) | Merck Sharp & Dohme LLC | 2012-05-22 |
| Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). (NCT01577563) | AstraZeneca | 2012-05-01 |
| Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device (NCT01618955) | Antares Pharma Inc. | 2012-05-01 |
| Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device (NCT01618968) | Antares Pharma Inc. | 2012-05-01 |
| Masitinib in Refractory Active Rheumatoid Arthritis (NCT01410695) | AB Science | 2011-07-01 |
| Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients (NCT01258712) | Chugai Pharma Taiwan | 2010-12-01 |
| Methotrexate - Inadequate Response Device Sub-Study (NCT01173120) | Bristol-Myers Squibb | 2009-11-01 |
| EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries (NCT01078402) | AbbVie (prior sponsor, Abbott) | 2009-04-01 |
| Methotrexate-Inadequate Response Study (NCT00559585) | Bristol-Myers Squibb | 2008-01-01 |
| Phase IIIB Subcutaneous Abatacept Monotherapy Study (NCT00547521) | Bristol-Myers Squibb | 2007-12-01 |
| Optimization of Treatment With Adalimumab (Humira) (NCT01585064) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-08-01 |
| Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114 (NCT00296257) | Dainippon Sumitomo Pharma Europe LTd. | 2006-02-01 |
| Dietary Factors and Rheumatoid Arthritis Risk in the UK Biobank (NCT06670183) | University of Leeds | 2006-01-01 |
| Diet and Rheumatoid Arthritis Risk in the United Kingdom Women's Cohort (NCT06670144) | University of Leeds | 1995-01-15 |